Dolutegravir 10 mg, 25 mg, 50 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg, 25 mg, 50 mg
Reference Brands: Tivicay(Us & EU)
Category: Anti Viral
Dolutegravir is an HIV-1 treatment from the integrase inhibitor class that blocks viral replication. Approved by the US FDA and EMA, it is used alone or in combination therapies like Tivicay, Triumeq, and Dovato. Known for strong efficacy and once-daily dosing.
Product Description:
Dolutegravir is a potent antiretroviral drug used for the treatment of HIV-1 infection. As an integrase strand transfer inhibitor (INSTI), it blocks the enzyme HIV integrase, preventing viral replication. Dolutegravir is available as a standalone medication (brand name Tivicay) and in fixed-dose combinations like Triumeq, Dovato, and Juluca. Approved by the US FDA and EMA, it is used in both adults and children. Known for its once-daily dosing, high genetic barrier to resistance, and strong efficacy, Dolutegravir is a preferred first-line HIV therapy recommended by WHO and leading HIV treatment guidelines globally. Ideal for long-term HIV management.
Dolutegravir — third party manufacturing & bulk supply
Dolutegravir 10 mg, 25 mg, 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Dolutegravir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Dolutegravir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Dolutegravir is used for the treatment of HIV-1 infection. It helps reduce viral load, increase CD4 counts, and is often used as part of combination antiretroviral therapy. It is effective, well-tolerated, and widely used in first-line HIV treatment regimens.
Dolutegravir is made from the active substance dolutegravir sodium, which is an integrase strand transfer inhibitor (INSTI). It works by blocking the integrase enzyme that HIV needs to replicate.
The main trade name is Tivicay.
Tivicay is manufactured by ViiV Healthcare.
The generic name is Dolutegravir (commonly available as dolutegravir sodium).
The brand name is Tivicay.
It is manufactured in the UK and Europe by ViiV Healthcare, while licensed generic versions are produced in India by approved pharmaceutical manufacturers.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
